35 Stocks Moving In Monday's Pre-Market Session

Gainers

• SINTX Technologies SINT rose 50% to $4.50 in pre-market trading after the company issued a business update.
• Mylan N.V. MYL rose 23.2% to $22.75 in pre-market trading after the company announced a business combination with Pfizer's Upjohn division. The company also reported better-than-expected Q2 results.
• Kindred Biosciences, Inc. KIN rose 21.2% to $8.15 in pre-market trading after reporting results from pilot field effectiveness study of its Interleukin-31 monoclonal antibody for the treatment of atopic dermatitis in dogs.
• Cidara Therapeutics Inc CDTX rose 16.3% to $1.86 in pre-market trading after the company reported topline results from its phase 2 STRIVE B trial of Antifungal Rezafungin. Rezafungin met its objectives for efficacy, safety and tolerability.
• Alterity Therapeutics Ltd ATHE rose 15.6% to $1.29 in pre-market trading after the company announced the completion of its Phase 1 clinical trial for PBT434. The drug was safe and well-tolerated, with adverse event rates comparable to placebo.
• Soligenix, Inc. SNGX shares rose 13.2% to $1.20 in pre-market trading after the company received European patents for Oral BDP in the treatment of acute radiation injury of the gastrointestinal tract.
• Genomic Health, Inc. GHDX shares rose 12.5% to $77.25 in pre-market trading after EXACT Sciences Corporation EXAS announced it will acquire the company for $72 per share. The company also reported better-than-expected Q2 EPS and sales results and raised its FY19 guidance.
• Tower Semiconductor Ltd. TSEM rose 10.9% to $20.32 in pre-market trading after the company reported better-than-expected Q2 EPS and sales results.
• Pieris Pharmaceuticals, Inc. PIRS rose 9.7% to $5.21 in pre-market trading. Pieris Pharma said on July 26, European Respiratory Society announced acceptance of late-breaking presentation of company's Phase 1 study of PRS-060.
• Anavex Life Sciences Corp. AVXL rose 8.6% to $2.77 in pre-market trading after receiving positive opinion for orphan designation from the European Medicines Agency for ANAVEX 2-73 for the treatment of Rett syndrome.
• Niu Technologies NIU rose 8.6% to $6.93 in pre-market trading. Niu Technologies is expected to release Q2 earnings on August 23, 2019.
• Booz Allen Hamilton Holding Corporation BAH rose 7% to $74.01 in pre-market trading after the company reported upbeat Q1 earnings results.
• Equinix, Inc. EQIX rose 6.8% to $521.81 in pre-market trading
• Wanda Sports Group Company Limited WSG shares rose 6.6% to $5.50 in pre-market trading after falling 35.50% on Friday.
• Safe-T Group Ltd SFET rose 6.5% to $1.32 in pre-market trading after the company announced a Tier-1 collaboration agreement for its IP proxy product with a Korean internet service provider.
• Teva Pharmaceutical Industries Limited TEVA rose 5.6% to $7.96 in pre-market trading following a merger between generic drug maker Mylan and Pfizer's off-patent Upjohn division.
• Xenetic Biosciences, Inc. XBIO rose 6.1% to $2.95 in pre-market trading after Anson Funds Management LP reported a 9.8% passive stake in the company.
• TCR2 Therapeutics Inc. TCRR shares rose 6.1% to $14.50 in pre-market trading after gaining 5.15% on Friday.
• Sanofi SA SNY rose 2.9% to $43.56 in pre-market trading after the company reported better-than-expected Q2 EPS and sales results.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Lexicon Pharmaceuticals, Inc. LXRX fell 52.2% to $2.72 in pre-market trading after the company received a written notice from Sanofi SNY terminating the agreement for the development and commercialization of the company's Diabetes drug candidate Sotagliflozin.
• Cooper Tire & Rubber Company CTB fell 11.3% to $27.00 in pre-market trading after the company reported worse-than-expected Q2 results.
• PolarityTE, Inc. PTE fell 10.9% to $4.10 in pre-market trading. PolarityTE is expected to release Q2 results on August 8..
• Exact Sciences Corporation EXAS fell 9.1% to $107.20 in pre-market trading after the company announced it will acquire Genomic Health for $72 per share in cash and stock.
• Rekor Systems, Inc. REKR shares fell 7.3% to $4.95 in pre-market trading after rising 16.85% on Friday.
• Broadcom Inc. AVGO fell 5.2% to $285.15 in pre-market trading.
• Oil States International, Inc. OIS fell 5.1% to $13.20 in pre-market trading following downbeat Q2 results.
• Smith Micro Software, Inc. SMSI fell 5% to $5.46 in pre-market trading after rising 66.67% on Friday.
• Tata Motors Limited TTM fell 5% to $10.05 in pre-market trading.
• Ra Pharmaceuticals, Inc. RARX fell 4.7% to $34.40 in pre-market trading. Raymond James downgraded Ra Pharmaceuticals from Strong Buy to Market Perform.
• Carbonite, Inc. CARB fell 4.6% to $17.18 in pre-market trading after declining 24.64% on Friday.
• SeaWorld Entertainment, Inc. SEAS fell 4% to $29.66 in pre-market trading.
• Vedanta Limited VEDL fell 3.7% to $9.14 in pre-market trading.
• Obalon Therapeutics, Inc. OBLN fell 3.3% to $6.29 in pre-market trading after climbing 21.72% on Friday.
• Achillion Pharmaceuticals, Inc. ACHN shares fell 3.2% to $4.50 in pre-market trading after gaining 18.02% on Friday.
• DISH Network Corp DISH fell 2.6% to $38.50 in pre-market trading after Barclays downgraded the stock from Equal-Weight to Underweight and announced a price target of $31 per share.